Lonza Group's earnings have been declining at an average annual rate of -0.3%, while the Life Sciences industry saw earnings declining at 3.8% annually. Revenues have been growing at an average rate of 7.3% per year. Lonza Group's return on equity is 11.4%, and it has net margins of 13.9%.
Key information
-0.28%
Earnings growth rate
0.89%
EPS growth rate
Life Sciences Industry Growth
21.51%
Revenue growth rate
7.27%
Return on equity
11.41%
Net Margin
13.92%
Next Earnings Update
22 Jul 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Lonza Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
OTCPK:LZAG.F Revenue, expenses and earnings (CHF Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Dec 25
6,531
909
813
112
30 Jun 25
7,093
733
1,138
118
31 Mar 25
6,834
685
1,083
118
31 Dec 24
5,480
601
733
102
30 Sep 24
6,635
605
1,000
112
30 Jun 24
6,696
573
972
105
31 Mar 24
6,707
614
956
105
31 Dec 23
6,717
654
940
105
30 Sep 23
6,518
892
960
100
30 Jun 23
6,319
1,129
979
95
31 Mar 23
6,271
1,172
972
95
31 Dec 22
6,223
1,215
965
95
30 Sep 22
6,036
1,062
965
93
30 Jun 22
5,849
909
964
90
31 Mar 22
5,629
792
930
90
31 Dec 21
5,409
674
896
90
30 Sep 21
5,108
612
868
87
30 Jun 21
4,807
550
839
84
31 Mar 21
4,658
640
840
84
31 Dec 20
4,508
730
840
84
30 Sep 20
3,135
656
476
117
30 Jun 20
3,474
696
604
75
31 Mar 20
3,841
672
704
75
31 Dec 19
4,207
647
804
75
30 Sep 19
5,821
710
1,183
55
30 Jun 19
5,722
658
1,068
110
31 Mar 19
5,632
657
1,050
110
31 Dec 18
5,542
655
1,032
110
30 Jun 18
5,034
826
929
95
31 Mar 18
4,791
745
880
95
31 Dec 17
4,548
664
831
95
30 Sep 17
4,758
527
891
94
30 Jun 17
4,423
334
833
84
31 Mar 17
4,278
318
783
84
31 Dec 16
4,132
301
732
84
30 Sep 16
4,025
331
672
94
30 Jun 16
3,918
360
611
103
31 Mar 16
3,861
319
574
103
31 Dec 15
3,803
277
536
103
30 Sep 15
3,774
243
529
102
30 Jun 15
3,744
208
521
101
Quality Earnings: LZAG.F has high quality earnings.
Growing Profit Margin: LZAG.F's current net profit margins (13.9%) are higher than last year (11%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: LZAG.F's earnings have declined by 0.3% per year over the past 5 years.
Accelerating Growth: LZAG.F's earnings growth over the past year (51.2%) exceeds its 5-year average (-0.3% per year).
Earnings vs Industry: LZAG.F earnings growth over the past year (51.2%) exceeded the Life Sciences industry 3.8%.
Return on Equity
High ROE: LZAG.F's Return on Equity (11.4%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/05/20 11:56
End of Day Share Price
2026/05/20 00:00
Earnings
2025/12/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Lonza Group AG is covered by 52 analysts. 23 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.